Asterand Share Price (ATD)
| Bid price | 0.00 | Open price | 0.00 |
|---|---|---|---|
| Ask price | 0.00 | Prev close | 1.63 |
| High price | 0.00 | Spread | 0.00% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Asterand share prices, Asterand stock quotes, charts, trades and FREE Asterand company fundamentals, market news and much much more. Why not upgrade to a premium service and get Asterand Level 2 Data, indepth research tools and investor commentary for Asterand (ATD) and other London Stock Exchange equities.
Asterand Share Price Chart
Register now for FREE Asterand share price charts
Asterand Share Price Information
| Name | Asterand | Epic | ATD |
|---|---|---|---|
| Activites | Identifies relevant human disease targets, and discovers and develops drug candidates using human tissue | Reuters | ATD.L |
| ISIN | GB0009231639 | Google Finance | LON:ATD |
| Share Price (p) | 0.00 | Prev. Share Price (p) | 1.63 |
|---|---|---|---|
| Shares in Issue (m) | 119 | Market Cap (£m) | 1 |
| PE Ratio (x) | -0.55 | Div per share (p) | 0.00 |
| Div yield (%) | 0.00 | Div cover (x) | |
| EPS (p) | -4.30 | PEG |
Register now for FREE Asterand company fundamentals
Asterand Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 13/06/2011 | BUY | Martyn Coombs | RES | 85,000 |
| 25/05/2011 | TIN | John Stchur | RES | 419,650 |
| 04/11/2010 | BUY | Martyn Coombs | RES | 80,000 |
| 31/03/2010 | BUY | Martyn Coombs | RES | 60,000 |
| 29/04/2009 | BUY | Martyn Coombs | RES | 37,000 |
Asterand Company News
Asterand revenues flat
Asterand's revenue for the period to the end of March was flat although the mix has changed with the Tissue business improving and BioSeek declining. The company says talks over the sale of the Tissue business are continuing and the board expects to send out a circular to shareholders in the...
Interim Management Statement
/* */ RNS Number : 6711D Asterand PLC 18 May 2012 ...
Asterand loses potential bidder for BioSeek business
The potential bidder for Asterand's BioSeek business has decided it will no longer pursue the acquisition. Asterand says the board continues to make good progress on the sale of its non-BioSeek Tissue Based Solutions business. But Asterand says the proceeds received from a successful disposal...
Register now for FREE Asterand company news
Asterand Share Price Discussions
MUST BUY A SURE GAINER, DOUBLE YOUR MONEY (ATD)
Only 100 million shares in issue, 6.25p to buy at present. I own these shares and expect this share to reach between 12-16p by september. it is very good value at present to buy. The company expects to announce its interim results for the six months ended 30 June 2006 in September. Based...
Register now for FREE Asterand share price discussions